Medite Cancer Diagnostics, Inc.
Medite Cancer Diagnostics, Inc. (MDIT) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 19 transactions totaling $4.1M, demonstrating a bullish sentiment with $4.1M in net insider flow. The most recent transaction on Oct 15, 2018 involved a purchase of 8,973,333 shares valued at $717.9K.
MDIT Insider Activity Summary
Who Is Buying MDIT Stock?
No significant insider buying has been recorded for MDIT in the recent period.
Who Is Selling MDIT Stock?
No significant insider selling has been recorded for MDIT in the recent period.
Is Medite Cancer Diagnostics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for MDIT is bullish with an Insider Alignment Score of 100/100 and a net flow of $4.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
MDIT Frequently Asked Questions
Understanding MDIT Insider Activity
Insider trading at Medite Cancer Diagnostics, Inc. (MDIT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading MDIT stock, having executed 19 transactions in the past 90 days. The most active insider is William Austin Lewis IV (Executive), who has made 9 transactions totaling $3.1M.
Related Tools
Track Medite Cancer Diagnostics, Inc. Insider Activity
Get notified when executives and directors at MDIT file new Form 4 transactions